To specifically elucidate the prognostic value of CD20 expression, we found that the predictive effects of CD20 intensity and CD20 proportion for survival could be applied to ALL patients with different clinical factors. The gene discussed is MS4A1; the disease is acute lymphoblastic leukemia.